Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07187180 · ClinicalTrials.gov registry record · NA
Evaluating the Clinical Efficacy of Thulio vs. Holmium Laser Enucleation of the Prostate
A NA study of BPH With Urinary Obstruction and BPH With Symptomatic Lower Urinary Tract Symptoms, sponsored by Smita De.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07187180: Recruiting NA study of BPH With Urinary Obstruction and BPH With Symptomatic Lower Urinary Tract Symptoms, sponsored by Smita De.
NCT07187180 is a NA study of BPH With Urinary Obstruction and BPH With Symptomatic Lower Urinary Tract Symptoms that is actively recruiting participants, run by Smita De. The registered enrollment target is 50 participants, below the 737-participant average among 3 other BPH With Urinary Obstruction trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07187180, a NA study of BPH With Urinary Obstruction and BPH With Symptomatic Lower Urinary Tract Symptoms, is actively recruiting participants, sponsored by Smita De.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Many consider laser enucleation of the prostate the new 'gold standard' for the surgical treatment of benign prostatic hyperplasia (BPH) due to its excellent outcomes, high success rates, and long-term efficacy. Holmium laser enucleation of the prostate (HoLEP) was the earliest form of prostate enucleation and is recommended by the American Urological Association (AUA), along with thulium laser enucleation of the prostate (ThuLEP), as size-independent techniques for the management of BPH with fewer complications than transurethral resection of the prostate (TURP). Further development of laser technology has additionally led to enucleation using pulsed-modulated (e.g. "Virtual Basket™" mode or MOSES™ mode) holmium lasers as well as the thulium fiber laser.
Primary Outcome
time required to get adequate hemostasis intraoperatively
Conditions Studied
Interventions
- DEVICE holmium laser
- DEVICE pulsed thulium laser
Study Locations (1)
Ohio
- Cleveland Clinic Main - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-06-02 |
| Est. Completion | 2026-09 |
| Phase | NA |
What NCT07187180 shows while recruiting
NCT07187180 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 737-participant average among 3 other BPH With Urinary Obstruction trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with BPH With Urinary Obstruction appearing as the primary indexed condition, and to 2 interventions - of which holmium laser is the first listed.
NCT07187180 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07187180 about?
NCT07187180 is a clinical study titled "Evaluating the Clinical Efficacy of Thulio vs. Holmium Laser Enucleation of the Prostate". Many consider laser enucleation of the prostate the new 'gold standard' for the surgical treatment of benign prostatic hyperplasia (BPH) due to its excellent outcomes, high success rates, and long-term efficacy. Holmium laser enucleation of the prostate (HoLEP) was the earliest form of prostate enuc...
What is the current status of trial NCT07187180?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-06-02. Estimated completion is 2026-09.
What conditions does trial NCT07187180 study?
This clinical trial studies the following conditions: BPH With Urinary Obstruction, BPH With Symptomatic Lower Urinary Tract Symptoms.
What interventions are being tested in trial NCT07187180?
The interventions under investigation include: holmium laser (DEVICE), pulsed thulium laser (DEVICE).
Who is sponsoring clinical trial NCT07187180?
This trial is sponsored by Smita De, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07187180 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for BPH With Urinary Obstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI